| Autor: |
Kiran, Kayyam, Sirisha, Chada, Aasim, Syed Ali |
| Předmět: |
|
| Zdroj: |
European Journal of Cardiovascular Medicine; 2023, Vol. 13 Issue 2, p742-754, 13p |
| Abstrakt: |
Aim: We carried this study to compare readymade 0.75% hyperbaric ropivacaine vs conventional 0.5% hyperbaric bupivacaine for elective C-sections. Methods: Our study included 60 parturients aged 18-30 years with ASA grades II who were scheduled for caesarean section. The parturients were randomly split into two groups of 30 each. Parturients in Group B received 0.5% hyperbaric bupivacaine 2ml (10mg), whereas those in Group R received 0.75% hyperbaric ropivacaine 2ml (10mg) (15mg). Results: The onset of motor anaesthesia was quantified in seconds as the achievement of Bromage scale II. Group B had a time of 97.5±33.82 and Group R had a time of 102.63±23.18 seconds. The P-value was significant (<0.05). The ultimate bromage scale obtained was measured in both groups, with 19 (63.33%) parturients out of 30 achieving Bromage III and 11 (36.66%) achieving Bromage IV in the ropivacaine group. In the ropivacaine, the median Bromage Scale was Bromage III. In the bupivacaine group, 13 out of 30 achieved Bromage III and 17 achieved Bromage IV. Two segment regressionwas quicker in Group R than in Group B. Conclusion: In caesarean sections, hyperbaric ropivacaine is an acceptable substitute for hyperbaric bupivacaine. The use of sterile 0.75% hyperbaric ropivacaine ampoulesis equivalent and even better than those hyperbaric ropivacaine solutions made artificially shortly before the treatment, is an extra benefit of the current research. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
